David Kreimer

Founder at MSM Protein Technologies, Inc.

Health Technology

Profile

David Kreimer has founded a company called MSM Protein Technologies, Inc. in the year 2005.
At MSM Protein Technologies, Inc., Dr. Kreimer holds the titles of President, Chief Operating Officer & Director.

David Kreimer active positions

Companies	Position	Start
MSM Protein Technologies, Inc. MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases.	Founder	2004-12-31

All active positions of David Kreimer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kreimer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
MSM Protein Technologies, Inc. MSM Protein Technologies, Inc. Pharmaceuticals: MajorHealth Technology MSM Protein Technologies is an early drug development company that specializes in antibody drug discovery against integral membrane proteins. MSM Protein Technologies is based in Waltham, MA and was founded in 2005 by Davis Farmer, Eldar Kim, and David Kreimer. The private company has a solid record of successful partnerships with big pharma companies in drug discovery and development programs. The company's pipeline includes a number of first-in-class pre-clinical stage antibodies targeting several GPCRs, mainly focused on immunologic and oncologic diseases such as blood cancers, solid tumors, autoimmune diseases, and respiratory diseases.	Health Technology